Categories: News

illumigyn™ Partners with Lambell Ghana Limited to distribute its cutting-edge Gynecological Imaging Platform and Cloud System to Ghana

JERUSALEM, Nov. 16, 2021 /PRNewswire/ — illumigyn, the world’s first remote gynecological imaging platform, announced today its new distribution agreement with Lambell Ghana Limited to deploy 850 Gynescopes in Ghana by 2026, to expand access to vital care for women worldwide.

Illumigyn is the first FDA-cleared remote gynecological platform. The illumigyn Gynescope™ digitally documents the cervix, vagina, and external genitalia, using high-resolution and superior magnification that enables more accurate pap smears. In addition, the digital documents are saved to the cloud to be used for remote diagnosis, ongoing medical supervision, and additional consultations – without the need to repeat the procedure. All Gynescopes connect to a secure cloud system that enables remote analysis and diagnosis.

Since the Gynescope can be operated by any trained caregiver (OB/GYN, GP, Midwife, Nurse Practitioner, and Physician Assistant) or a nurse practitioner, it opens up the ability for women to be screened and diagnosed even in remote locations without physical access to physicians.

“This partnership will be life-changing for women in Ghana,” said Kwadwo Pocu, Director at Lambell Ghana Limited. “Cervical cancer ranks as the 2nd most frequent cancer among women in Ghana and the 2nd most frequent cancer among women between 15 and 44 years of age. Together with illumgyn, we hope to revolutionize women’s healthcare and quality of life in Ghana by making it accessible and affordable.”

“We established illumigyn to democratize women’s healthcare and to bring advanced gynecological care to women worldwide – including cervical screening,” adds Mr. Ran Poliakine, illumigyn’s Founder. “We have signed on to the WHO initiative to eradicate cervical cancer within a generation and are are proud to be part of driving change across Africa.”

About Illumigyn

illumigyn, founded by Ran Poliakine and Lior Greenstein, is an Israeli corporation focused on powering women’s health and making it accessible and affordable for every woman worldwide. Illumigyn’s vision is to disrupt the medical field of gynecology with a complete platform solution featuring the Gynescope™ System, a revolutionary and FDA cleared “gynecology endoscope” and cloud platform service. With our technological know-how and expertise, our vision is to then create an ecosystem that powers all facets of women’s health. For more information, please visit https://www.illumigyn.com/.

Media Contact:

Justine Rosin
Headline Media
Justine@headline.media
IL:+972 54 885 9141
US:+1 917 724 2176

 

 

View original content:https://www.prnewswire.com/news-releases/illumigyn-partners-with-lambell-ghana-limited-to-distribute-its-cutting-edge-gynecological-imaging-platform-and-cloud-system-to-ghana-301425343.html

SOURCE illumigyn

Staff

Recent Posts

Attune to Support Poppy Health’s $39M ARPA-H BREATHE Project in the U.S. Schools

VIENNA, Va., Dec. 19, 2025 /PRNewswire/ -- Attune announced today that the company will play…

1 hour ago

Feel30 Launches Austin-Based Telehealth Platform for Evidence-Proven TRT & Integrated At-Home Phlebotomy Services

AUSTIN, Texas, Dec. 19, 2025 /PRNewswire/ -- Feel30 , a telehealth platform specializing in testosterone…

1 hour ago

LISA LING JOINS TENDERCARE AS CHIEF CAREGIVER ADVOCATE & ADVISOR

– Will help address the difficult realities sandwich generation caregivers face with family caregiving –NEW…

1 hour ago

TENDERCARE LAUNCHING NATIONAL FAMILY CAREGIVING INFRASTRUCTURE, PARTNERING WITH THE AGING LIFE CARE ASSOCIATION® AND SUPPORTING THE CMS GUIDE MODEL PROGRAM

tendercare partnering with ALCA to raise national caregiving and eldercare industry standards;Selected as CMS GUIDE…

1 hour ago

HCAP Partners Announces Investment in Puzzle Healthcare

Investment to accelerate the growth of a post-acute care platform focused on reducing hospital readmissions…

1 hour ago

The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute

IRVING, Texas, Dec. 19, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation…

1 hour ago